Mosaic ImmunoEngineering (OTCMKTS:CPMV) Issues Quarterly Earnings Results

Mosaic ImmunoEngineering (OTCMKTS:CPMVGet Free Report) posted its earnings results on Tuesday. The company reported ($0.04) earnings per share (EPS) for the quarter, reports.

Mosaic ImmunoEngineering Stock Down 2.5 %

Shares of OTCMKTS:CPMV opened at $0.39 on Friday. The company has a 50 day moving average price of $0.42 and a two-hundred day moving average price of $0.51. Mosaic ImmunoEngineering has a 52 week low of $0.10 and a 52 week high of $1.00.

Mosaic ImmunoEngineering Company Profile

(Get Free Report)

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.

Featured Articles

Earnings History for Mosaic ImmunoEngineering (OTCMKTS:CPMV)

Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.